FSTX NASDAQ
F-star Therapeutics, Inc.
1W: +27.1%
1M: +49.0%
3M: +28.3%
1Y: +143.0%
$7.12
Last traded 2023-03-08 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$27M
-68.0% ▼
Capital Expenditures
$658K
+9.9% ▲
5Y CAGR: +25.3%
Free Cash Flow
-$28M
-64.7% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$60M
+340.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$28M | -$23M | -$23M | -$26M | -$31M |
| Depreciation & Amort. | $158K | $288K | $844K | $1M | $642K |
| Stock-Based Comp. | $2M | $3M | $3M | $3M | $7M |
| Change in Working Capital | $181K | $180K | -$9M | $1M | -$5M |
| Other Non-Cash Items | $8M | -$5M | $2M | $3M | $2M |
| Operating Cash Flow | -$18M | -$25M | -$22M | -$16M | -$27M |
| — Investing Activities — | |||||
| Capital Expenditures | -$323K | -$2M | -$127K | -$730K | -$658K |
| Acquisitions (Net) | $0 | $0 | $5M | $0 | $0 |
| Investment Purchases | -$34M | -$58M | -$15M | $0 | $0 |
| Investment Sales | $22M | $35M | $39M | $5M | $0 |
| Other Investing | $0 | $0 | -$24M | $10M | $15K |
| Investing Cash Flow | -$12M | -$25M | $5M | $14M | -$643K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $44M | $41M | $13M | $16M | $88M |
| Financing Cash Flow | $44M | $41M | $13M | $16M | $88M |
| Net Change in Cash | $13M | -$9M | -$3M | $14M | $60M |
| Cash End of Period | $24M | $15M | $5M | $19M | $79M |
| Free Cash Flow | -$18M | -$27M | -$22M | -$17M | -$28M |